IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
Accounts Receivables
IsoPlexis Corp
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IsoPlexis Corp
NASDAQ:ISO
|
Accounts Receivables
$4.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$9.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Receivables
$650.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is IsoPlexis Corp's Accounts Receivables?
Accounts Receivables
4.5m
USD
Based on the financial report for Dec 31, 2022, IsoPlexis Corp's Accounts Receivables amounts to 4.5m USD.
What is IsoPlexis Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
17%
Over the last year, the Accounts Receivables growth was 10%. The average annual Accounts Receivables growth rates for IsoPlexis Corp have been 17% over the past three years .